Monsenso A/S (CPH:MONSO)
Denmark · Delayed Price · Currency is DKK 0.2800
+0.0400 (16.67%)
Aug 17, 2026, 4:59 PM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 26.85 million as of August 17, 2026. Its market cap has increased by 76.39% in one year.
Market Cap
26.85M
Enterprise Value
28.64M
Revenue
8.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.28
ChartMarket Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 26.85M, a decrease of -72.28%. That is a compound annual growth rate of -18.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 26.85M | 168.11% |
| Dec 30, 2025 | 10.02M | -59.16% |
| Dec 30, 2024 | 24.52M | 177.63% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.30T |
| Genmab | 121.01B |
| Coloplast | 96.44B |
| Demant | 62.72B |
| Gubra | 6.07B |
| BioPorto | 591.66M |
| ViroGates | 101.17M |
| Pharma Equity Group | 100.17M |